
Electromed (ELMD) Stock Forecast & Price Target
Electromed (ELMD) Analyst Ratings
Bulls say
Electromed Inc. reported a significant 14.8% growth in homecare revenue, reaching $14.1 million, driven by improved sales rep productivity, streamlined reimbursement processes, and effective demand generation strategies. The company has established a robust presence in the domestic homecare market while also expanding into acute care and select international regions, enhancing its growth potential. Additionally, the 17.2% rise in selling, general and administrative (SG&A) expenses, attributed to increased headcount in key areas, underscores Electromed's commitment to investing in growth and supporting its expanding operations.
Bears say
Electromed Inc faces a negative outlook primarily due to margin compression, competitive headwinds, and reduced sales rep productivity, which are significant concerns affecting its financial performance. The company has experienced a notable decline in its stock price, dropping from a recent high of $35.43 to approximately $18, highlighting a troubling downward trend. These factors, combined with the competitive landscape, suggest challenges for Electromed in maintaining sales momentum and profitability going forward.
This aggregate rating is based on analysts' research of Electromed and is not a guaranteed prediction by Public.com or investment advice.
Electromed (ELMD) Analyst Forecast & Price Prediction
Start investing in Electromed (ELMD)
Order type
Buy in
Order amount
Est. shares
0 shares